Learn how to protect biological drug innovations during this webinar from Stockholm Science City (In Swedish). Ulrika Munter and Nora Spjuth share their experiences working with intellectual property in this field and Linus Plym Forshell from the Swedish Intellectual Property Office (PRV) provides an overview of IP strategies in the pharmaceutical sector. This webinar is in Swedish.
Protecting Biological Drug Innovations
You may also be interested in:
EPO launches new PPH agreements with New Zealand and Bahrain
The PPH network continues to expand, and we at AWA remain one step ahead by closely monitoring the new
Increasing Burden of Proof for Trademark Applicants in China
Based on the recent official notices issued by the CNIPA (China National Intellectual Property Administration) about non-use cancellation cases,
Companies with IP generate at least 23.8% more revenue according to latest EU report
The report ‘The Intellectual Property Rights and Firm Performance in the European Union’ was published last month and analyses